Literature DB >> 12960486

Henoch-Schonlein purpura.

Susan Ballinger1.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to educate the reader about the one of the most common vasculitides of childhood: Henoch-Schonlein purpura. Although the disease has been described for over a century, the etiology has yet to be discovered. Adult-onset Henoch-Schonlein purpura is unusual, but through case studies, this review examines some of the common manifestations of this presentation of disease. Long-term outcome studies are still defining how this disease affects a small but significant percentage of patients afflicted with Henoch-Schonlein purpura. RECENT
FINDINGS: This article will summarize recent work in molecular biology and genetics evaluating predisposing factors in the development of Henoch-Schonlein purpura. Further illustrations of the various complications of Henoch-Schonlein purpura will be reviewed. Recent long-term studies of outcomes of patients with renal disease from Henoch-Schonlein purpura will be summarized.
SUMMARY: After reading this review, the clinician will be able to elucidate the manifestations of Henoch-Schonlein purpura, determine appropriate treatment of the disease, and, most importantly, give the patient information about long-term consequences of Henoch-Schonlein purpura.

Entities:  

Mesh:

Year:  2003        PMID: 12960486     DOI: 10.1097/00002281-200309000-00012

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  12 in total

1.  Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway.

Authors:  Y-H Yang; Y-H Huang; Y-L Lin; L-C Wang; Y-H Chuang; H-H Yu; Y-T Lin; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Henoch-Schönlein purpura in an older man presenting as rectal bleeding and IgA mesangioproliferative glomerulonephritis: a case report.

Authors:  Wisit Cheungpasitporn; Teeranun Jirajariyavej; Charles B Howarth; Raquel M Rosen
Journal:  J Med Case Rep       Date:  2011-08-10

Review 3.  Dermacase. Henoch-Schönlein purpura.

Authors:  Anatoli Freiman
Journal:  Can Fam Physician       Date:  2005-04       Impact factor: 3.275

4.  Henoch-Schönlein purpura: a case with atypical presentation.

Authors:  Mukaddes Kalyoncu; Murat Cakir; Erol Erduran; Aysenur Okten
Journal:  Rheumatol Int       Date:  2005-09-23       Impact factor: 2.631

Review 5.  Bariatric surgery and its effects on the skin and skin diseases.

Authors:  Ali Halawi; Firass Abiad; Ossama Abbas
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

6.  Pulmonary renal syndrome in an adult patient with Henoch-Shönlein purpura.

Authors:  Th Eleftheriadis; V Liakopoulos; M Boulbou; F Karasavvidou; E Atmatzidis; S Dovas; G Antoniadi; I Stefanidis
Journal:  Hippokratia       Date:  2006-10       Impact factor: 0.471

7.  Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion.

Authors:  Andrew A O Fagbemi; Franco Torrente; Andrew J W Hilson; Michael A Thomson; Robert B Heuschkel; Simon H Murch
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

8.  Angiotensin-converting enzyme gene insertion/deletion polymorphism in children with Henoch-Schonlein purpua nephritis.

Authors:  Jianhua Zhou; Xuefei Tian; Qinru Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

9.  A Case of Henoch-Schönlein Purpura with P369S Mutation in MEFV Gene.

Authors:  Pelin Ertan; Gökhan Tekin; Gülseren Evirgen Sahin; Erhun Kasırga; Fatma Taneli; Ali Riza Kandioğlu; Betül Sözeri
Journal:  Iran J Pediatr       Date:  2011-06       Impact factor: 0.364

10.  Henoch-Schönlein Purpura in adults.

Authors:  María José López Meiller; Javier Alberto Cavallasca; María del Rosario Maliandi; Gustavo Guillermo Nasswetter
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.